For research use only. Not for therapeutic Use.
Tetrahydrozoline (Cat No.:I014816), a derivative of imidazoline, is an α-adrenergic (α-adrenergic) agonist that causes vasoconstriction. Tetrahydrozoline is widely used in the study of nasal congestion and conjunctival congestion. If you need, please contact us in time, and we will reply to you as soon as possible within 24 hours.
| Catalog Number | I014816 |
| CAS Number | 84-22-0 |
| Molecular Formula | C₁₃H₁₆N₂ |
| Purity | ≥95% |
| Target | Neuronal Signaling |
| IUPAC Name | 2-(1,2,3,4-tetrahydronaphthalen-1-yl)-4,5-dihydro-1H-imidazole |
| InChI | InChI=1S/C13H16N2/c1-2-6-11-10(4-1)5-3-7-12(11)13-14-8-9-15-13/h1-2,4,6,12H,3,5,7-9H2,(H,14,15) |
| InChIKey | BYJAVTDNIXVSPW-UHFFFAOYSA-N |
| SMILES | C1CC(C2=CC=CC=C2C1)C3=NCCN3 |
| Reference | [1]. E Kisilevsky, et al. Anterior and posterior segment vasculopathy associated with long-term use of tetrahydrozoline. CMAJ. 2018 Oct 9;190(40):E1208.<br>[2]. Judy Peat, et al.Determination of tetrahydrozoline in urine and blood using gas chromatography-mass spectrometry (GC-MS). Methods Mol Biol. 2010;603:501-8. <br>[3]. Danuta Nowakowska, et al. In vitro effects of vasoconstrictive retraction agents on primary human gingival fibroblasts. Exp Ther Med. 2020 Mar; 19(3): 2037-2044. |
